ARYx Therapeutics
closedPharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.
Launch date
Employees
Market cap
$238k
Enterprise valuation
$238k (Public information from Sep 2024)
Share price
$0.0005 ARYX
Fremont California (HQ)
Authorizing premium user...